Elanco Animal Health (ELAN) Receivables - Other (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Receivables - Other data on file, last reported at $70.0 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 22.22% year-over-year to $70.0 million; the trailing twelve-month figure through Mar 2026 stood at $70.0 million (down 22.22% YoY), and the FY2025 full-year result was $67.0 million, down 17.28% from the prior year.
• Receivables - Other grew to $70.0 million in Q1 2026, from $67.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $225.0 million in Q2 2023 to a low of $64.0 million in Q3 2024.
• A 5-year average of $142.8 million and a median of $114.0 million in 2025 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other soared 110.58% in 2022 and sank 71.43% in 2024, its largest moves.
• Tracing ELAN's Receivables - Other over 5 years: stood at $205.0 million in 2022, then slipped by 18.05% to $168.0 million in 2023, then plunged by 51.79% to $81.0 million in 2024, then decreased by 17.28% to $67.0 million in 2025, then increased by 4.48% to $70.0 million in 2026.
• Business Quant data shows ELAN's Receivables - Other at $70.0 million in Q1 2026, $67.0 million in Q4 2025, and $81.0 million in Q3 2025.